Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Sae Won Kim"'
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
Clonal cell line-based, multigene-modified, off-the-shelf NK cell therapeutics are emerging as the new frontier of adoptive cellular immunotherapy. Here, we utilized a newly established NK cell line, NK101, as a backbone to derive multifaceted killer
Externí odkaz:
https://doaj.org/article/04d3c3e935ba4e87863dea889393011a
Autor:
Hyun Gul Yang, Moon Cheol Kang, Tae Yoon Kim, Injung Hwang, Hyun Tak Jin, Young Chul Sung, Ki-Seong Eom, Sae Won Kim
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-17 (2019)
Abstract Background Human natural killer (NK) cell lines serve as an attractive source for adoptive immunotherapy, but NK-92 remains the only cell line being assessed in the clinic. Here, we established a novel NK cell line, NK101, from a patient wit
Externí odkaz:
https://doaj.org/article/499f0496ddc647249cafdd327624c8be
Autor:
Young Chul Sung, Sin-Soo Jeun, Seong Muk Kim, Young Woo Choi, Moon Cheol Kang, Hyun Gul Yang, Sang Hoon Park, Su Jin Kim, Sae Won Kim
PDF file - 58K, Dose-dependent induction of apoptosis by dodecameric TRAIL expressing MSCs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41e8b874d7dea8e5299bb0df3e37f643
https://doi.org/10.1158/1078-0432.22455159
https://doi.org/10.1158/1078-0432.22455159
Autor:
Young Chul Sung, Sin-Soo Jeun, Seong Muk Kim, Young Woo Choi, Moon Cheol Kang, Hyun Gul Yang, Sang Hoon Park, Su Jin Kim, Sae Won Kim
PDF file - 125K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::630c9e5d4ce39b826e7682b7eb758ac9
https://doi.org/10.1158/1078-0432.22455156.v1
https://doi.org/10.1158/1078-0432.22455156.v1
Autor:
Young Chul Sung, Sin-Soo Jeun, Seong Muk Kim, Young Woo Choi, Moon Cheol Kang, Hyun Gul Yang, Sang Hoon Park, Su Jin Kim, Sae Won Kim
Purpose: Durable complete remission of metastatic renal cell carcinoma (RCC) has rarely been achieved with current treatment modalities. To solve this problem, alternative therapeutic options with high efficacy and minimal side effects are strongly n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::833f06cbec9c7782fa4d20ff8e9c8202
https://doi.org/10.1158/1078-0432.c.6522948
https://doi.org/10.1158/1078-0432.c.6522948
Autor:
Young Chul Sung, Sin-Soo Jeun, Seong Muk Kim, Young Woo Choi, Moon Cheol Kang, Hyun Gul Yang, Sang Hoon Park, Su Jin Kim, Sae Won Kim
PDF file - 122K, Phenotype of na�ve and engineered MSCs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a523a61eef6c75ef4d0943ae48c19b0
https://doi.org/10.1158/1078-0432.22455162.v1
https://doi.org/10.1158/1078-0432.22455162.v1
Autor:
Sae won Kim
Publikováno v:
EPISTÉMÈ. 21:49-68
Autor:
Young Chul Sung, Ki-Seong Eom, Sae Won Kim, Moon Cheol Kang, Hyun Gul Yang, Hwang Injung, Hyun Tak Jin, Tae Yoon Kim
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-17 (2019)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Background Human natural killer (NK) cell lines serve as an attractive source for adoptive immunotherapy, but NK-92 remains the only cell line being assessed in the clinic. Here, we established a novel NK cell line, NK101, from a patient with extra-n
Autor:
Sae Won Kim, Sae Won Chung
Publikováno v:
EPISTÉMÈ. 20:126-149
Autor:
Sae Won Kim, Sae Won Chung
Publikováno v:
EPISTÉMÈ. 18:52-83